Abstract:Background: Paroxysmal kinesigenic dyskinesia is the most common type of paroxysmal dyskinesia. Approximately half of the cases of paroxysmal kinesigenic dyskinesia worldwide are attributable to proline-rich transmembrane protein 2 mutations. Objective: The objective of this study was to investigate potential causative genes and clinical characteristics in proline-rich transmembrane protein 2-negative patients with paroxysmal kinesigenic dyskinesia. Methods: We analyzed clinical manifestations and performed exome sequencing in a cohort of 163 proline-rich transmembrane protein 2-negative probands, followed by filtering data with a paroxysmal movement disorders gene panel. Sanger sequencing, segregation analysis, and phenotypic reevaluation were used to substantiate the findings. Results: The clinical characteristics of the enrolled 163 probands were summarized. A total of 39 heterozygous variants were identified, of which 33 were classified as benign, likely benign, and uncertain significance. The remaining 6 variants (3 novel, 3 documented) were pathogenic and likely pathogenic. Of these, 3 were de novo (potassium calcium-activated channel subfamily M alpha 1, c.1534A>G; solute carrier family 2 member 1, c.418G>A; sodium voltage-gated channel alpha subunit 8, c.3640G>A) in 3 sporadic individuals, respectively. The other 3 (paroxysmal nonkinesiogenic dyskinesia protein, c.956dupA; potassium voltage-gated channel subfamily A member 1, c.765C>A; Dishevelled, Egl-10, and Pleckstrin domain containing 5, c.3311C>T) cosegregated in 3 families. All 6 cases presented with typical paroxysmal kinesigenic dyskinesia characteristics, except for the Dishevelled, Egl-10, and Pleckstrin domain containing 5 family, where the proband's mother had abnormal discharges in her temporal lobes in addition to paroxysmal kinesigenic dyskinesia episodes. Conclusions: Our findings extend the genotypic spectrum of paroxysmal kinesigenic dyskinesia and establish the associations between paroxysmal kinesigenic dyskinesia and genes classically related to other paroxysmal movement disorders. De novo variants might be a cause of sporadic paroxysmal kinesigenic dyskinesia. (c) 2018 International Parkinson and Movement Disorder Society

Prokineticins and their G protein-coupled receptors in health and disease.

Structural Determinants Required for the Bioactivities of Prokineticins and Identification of Prokineticin Receptor Antagonists

Genetic Polymorphisms of Prokineticins and Prokineticin Receptors Associated with Human Disease

PROKR2 Mutations in Idiopathic Hypogonadotropic Hypogonadism: Selective Disruption of the Binding to a Gα‐protein Leads to Biased Signaling

Disease-causing Mutation in PKR2 Receptor Reveals a Critical Role of Positive Charges in the Second Intracellular Loop for G-protein Coupling and Receptor Trafficking

Novel mutation of the PRRT2 gene in two cases of paroxysmal kinesigenic dyskinesia: Two case reports

A functional spectrum of PROKR2 mutations identified in isolated hypogonadotropic hypogonadism

Functional Analysis of the Distal Region of the Third Intracellular Loop of PROKR2.

Loss-of-function Mutation in the Prokineticin 2 Gene Causes Kallmann Syndrome and Normosmic Idiopathic Hypogonadotropic Hypogonadism

The PROK2/PROKR2 Signaling Pathway is Required for the Migration of Most Olfactory Bulb Interneurons

Pleiotropic role of prokineticin 1 in the porcine endometrium during pregnancy establishment and embryo implantation †

Impaired Pain Sensation in Mice Lacking Prokineticin 2

Biochemical characterization of Prokineticin 2 binding to Prokineticin receptor 1 in zebrafish

Prokineticin receptor 1 ameliorates insulin resistance in skeletal muscle

Prokineticin 2 is a Catabolic Regulator of Osteoarthritic Cartilage Destruction in Mouse.

[Analysis of PROKR2 Gene Mutation in Patients with Hypogonadotropic Hypogonadism].

Pathophysiological roles of G-protein-coupled receptor kinases

G protein-coupled receptor kinases: More than just kinases and not only for GPCRs

Identifying Prokineticin2 as a Novel Immunomodulatory Factor in Diagnosis and Treatment of Sepsis

Functional Rescue of Kallmann Syndrome-associated Prokineticin Receptor 2 (PKR2) Mutants Deficient in Trafficking

Proline-rich Transmembrane Protein 2-Negative Paroxysmal Kinesigenic Dyskinesia: Clinical and Genetic Analyses of 163 Patients.